Thursday, July 25, 2019

AASLD guidelines for treatment of chronic hepatitis B in pregnancy

Hello!

Here is a quick summary.


All infants of HBsAg-positive women should receive HBV vaccination ± hepatitis B immunoglobulin.

Pregnant women who have hepatitis B virus DNA levels greater than 200,000 IU/mL at 24 to 28 weeks' gestation should be treated with antivirals to prevent vertical transmission during delivery.

Antivirals studied in pregnant women: Lamivudine, telbivudine, and tenofovir.

Antiviral therapy was discontinued at birth to 3 months postpartum. With discontinuation of treatment, women should be monitored for ALT flares every 3 months for 6 months.

Breastfeeding is not contraindicated - antivirals are minimally excreted in breast milk.

C-section is not indicated - insufficient data to support benefit.

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987259/

-IkaN

3 comments:

  1. I think you need to rethink regarding title of this blog

    ReplyDelete
  2. Hey, I am so thrilled I found your blog, I am here now and could just like to say thank for a tremendous post and all round interesting website. Please do keep up the great work. I cannot be without visiting your blog again and again. frutas para la disfuncion erectil

    ReplyDelete

This is express yourself space. Where you type create something beautiful! <3
Wondering what do I write? Well..
Tell us something you know better. You are a brilliant mind. Yes, you are! ^__^
Ask about something you don't understand @_@?
Compliment... Say something nice! =D
Be a good critic and correct us if something went wrong :|
Go ahead. Comment all you like here! (: